Excitatory amino acids as therapeutic agents: Reversing neurodegenerative trajectory by tackling excitotoxicity
Neurological Sciences · 2025-02 · 46 (2) · 549-560
DOI: 10.1007/s10072-024-07880-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurological Sciences, online erschienen am 15.11.2024. Verfasst von Yogita Dhurandhar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh, 495009, India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Excitatory Amino Acids, Neuroprotective Agents, Receptors, N-Methyl-D-Aspartate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
Neurodegenerative diseases pose significant challenges to healthcare systems globally due to their complex etiology and relentless progression, often rendering conventional treatments ineffective. Recent advances have spotlighted excitatory amino acids, particularly D-amino acids, once considered as products of metabolism of the microbiota or deriving from food intake. This review explores the role of D-amino acids in mitigating excitotoxicity-a process characterized by excessive calcium influx through aberrant N-methyl-D-aspartate receptor (NMDAR) activation, which is implicated in the pathogenesis of diseases like Alzheimer's disease. By providing alternative pathways for neuronal signaling and protecting against excitotoxic damage, D-amino acids offer a novel approach to reversing neurodegenerative trajectories. Future research should focus on elucidating the detailed mechanisms of action of these compounds, evaluating their therapeutic potential through rigorous preclinical and clinical trials, and developing effective delivery systems to optimize their neuroprotective effects. This emerging field holds promise for developing innovative treatment strategies that could significantly improve outcomes for patients with neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh, 495009, India.
- National Coordination Centre, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India, Sector 23, Rajnagar, Ghaziabad, 201002, Uttar Pradesh, India…
Zitieren
APA
Dhurandhar, Y., Tomar, S., Namdeo, K. P., & Bodakhe, S. H. (2025). Excitatory amino acids as therapeutic agents: Reversing neurodegenerative trajectory by tackling excitotoxicity. Neurological Sciences, 46(2), 549-560. https://doi.org/10.1007/s10072-024-07880-3
Vancouver
Dhurandhar Y, Tomar S, Namdeo KP, Bodakhe SH. Excitatory amino acids as therapeutic agents: Reversing neurodegenerative trajectory by tackling excitotoxicity. Neurological Sciences. 2025;46(2):549-560. doi:10.1007/s10072-024-07880-3
BibTeX
@article{Dhurandhar2025,
author = {Dhurandhar, Yogita and Tomar, Shubham and Namdeo, Kamta P and Bodakhe, Surendra H},
title = {Excitatory amino acids as therapeutic agents: Reversing neurodegenerative trajectory by tackling excitotoxicity},
journal = {Neurological Sciences},
year = {2025},
volume = {46},
number = {2},
pages = {549--560},
doi = {10.1007/s10072-024-07880-3}
}
EUVIMED